Kryger Capital LLC

HAMILTON, null · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.64B2026 Q3+ $202.3M options (notional, not included)
Positions82
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.77.2%

Kryger Capital LLC reported 82 positions worth $1.64B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: WBD (14.7%). Biggest move: add ROKU ($197.4M).

10 / 82 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 WBDWarner Bros. Discovery$271.6M14.71%8,773,984——0.0%
▸ 2 ROKURoku$260.6M14.12%1,711,545——+5.4%
▸ 3 NSCNorfolk Southern$250.0M13.55%809,138——+6.6%
▸ 4 AESAes$158.5M8.59%10,638,542——+0.3%
▸ 5Warner Bros D…PutWarner Bros Discovery$150.2M notional8.14%4,853,100———
▸ 6 VALValaris$101.3M5.49%1,290,037——+1.3%
▸ 7 SLABSilicon Laboratories$75.6M4.10%341,189——-0.1%
▸ 8 CZRCaesars Entertainment$74.6M4.04%2,514,455——-0.9%
▸ 9 ARXAccelerant$46.9M2.54%2,376,448——+0.7%
▸ 10Warner Bros D…CallWarner Bros Discovery$36.1M notional1.96%1,167,200———

Pro Feature

The remaining 72 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Kryger Capital LLC hold as of Q3 2026?

Kryger Capital LLC reported 82 positions worth $1.64B in its Q3 2026 13F filing. Largest positions: WBD (14.7%), ROKU (14.1%), NSC (13.5%), AES (8.6%) and WARNER BROS DISCOVERY INC (8.1%).

What did Kryger Capital LLC buy in Q3 2026?

New positions: WARNER BROS DISCOVERY INC, VAL, ARX, WARNER BROS DISCOVERY INC and ACVA (30 in all). Added to: ROKU, WBD, AES, CZR and NSC (18 in all).

What did Kryger Capital LLC sell in Q3 2026?

Reduced: BHF, OGN, TMTS, CRAN and SAC (33 in all). Sold out entirely: GTLSGBP, KVUE, DBRG, EA* and APOGEE THERAPEUTICS ORD (57 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.